These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28498925)

  • 1. A case report of anaphylaxis to Typhoid Vaccine Live Oral Ty21a (Vivotif).
    Haas NL; Haas MRC; Gregory C
    J Travel Med; 2017 Sep; 24(5):. PubMed ID: 28498925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient compliance in the use of Vivotif Berna(R) vaccine, typhoid vaccine, live oral Ty21a.
    Wiedermann G
    J Travel Med; 1998 Mar; 5(1):1-2. PubMed ID: 9772307
    [No Abstract]   [Full Text] [Related]  

  • 3. Patient compliance in the use of Vivotif Berna(R) vaccine, typhoid vaccine, live oral Ty21a.
    Cryz SJ
    J Travel Med; 1998 Mar; 5(1):14-7. PubMed ID: 9772310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh.
    Bhuiyan TR; Choudhury FK; Khanam F; Saha A; Sayeed MA; Salma U; Lundgren A; Sack DA; Svennerholm AM; Qadri F
    Vaccine; 2014 Feb; 32(9):1055-60. PubMed ID: 24440210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of active component US military personnel against Salmonella Typhi.
    Porter CK; Sorrell T; Mitra I; Riddle MS
    Vaccine; 2017 Mar; 35(14):1742-1748. PubMed ID: 28268075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of the impact of Typhoid and Paratyphoid fever. Utility of Ty21a vaccine (Vivotif®).
    Amicizia D; Arata L; Zangrillo F; Panatto D; Gasparini R
    J Prev Med Hyg; 2017 Mar; 58(1):E1-E8. PubMed ID: 28515625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with live, oral Ty21a typhoid vaccine.
    Kaplan DT; Hill DR
    JAMA; 1992 Feb; 267(8):1074. PubMed ID: 1735924
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults.
    Alberer M; Burchard G; Jelinek T; Reisinger E; Beran J; Hlavata LC; Forleo-Neto E; Dagnew AF; Arora AK
    J Travel Med; 2015; 22(1):48-56. PubMed ID: 25308927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Typhoid vaccines.
    Aggarwal A; Dutta AK
    Indian J Pediatr; 2001 Aug; 68(8):733-6. PubMed ID: 11563251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance to live oral Ty21a typhoid vaccine, and its effect on viability.
    Stubi CL; Landry PR; Pétignat C; Bille J; Genton B; Darioli R; Burnier M
    J Travel Med; 2000; 7(3):133-7. PubMed ID: 11179942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccines.
    Tsai TF; Kollaritsch H; Que JU; Cropp CB; Kunz C; Wiedermann G; Herzog C; Cryz SJ
    J Infect Dis; 1999 Feb; 179(2):522-4. PubMed ID: 9878043
    [No Abstract]   [Full Text] [Related]  

  • 13. Comment on: evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh.
    Arya SC; Agarwal N
    Vaccine; 2014 Jul; 32(32):4013. PubMed ID: 24831232
    [No Abstract]   [Full Text] [Related]  

  • 14. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity.
    Engels EA; Falagas ME; Lau J; Bennish ML
    BMJ; 1998 Jan; 316(7125):110-6. PubMed ID: 9462316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Japanese study to assess immunogenicity and safety of a typhoid Vi polysaccharide vaccine.
    Miyazu M; Kikuchi H; Hamada A; Fukushima S; Ouchi K; Bosch Castells V; Mihara H; Bonnet MC
    Vaccine; 2015 Nov; 33(48):6697-702. PubMed ID: 26518404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vivotif--a 'magic shield' for protection against typhoid fever and delivery of heterologous antigens.
    Gentschev I; Spreng S; Sieber H; Ures J; Mollet F; Collioud A; Pearman J; Griot-Wenk ME; Fensterle J; Rapp UR; Goebel W; Rothen SA; Dietrich G
    Chemotherapy; 2007; 53(3):177-80. PubMed ID: 17347563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study.
    Mitra M; Shah N; Ghosh A; Chatterjee S; Kaur I; Bhattacharya N; Basu S
    Hum Vaccin Immunother; 2016 Apr; 12(4):939-45. PubMed ID: 26901576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response on letter by Arya et al.: "evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh.".
    Bhuiyan TR; Choudhury FK; Khanam F; Saha A; Sayeed MA; Salma U; Qadri F; Lundgren A; Svennerholm AM; Sack DA
    Vaccine; 2014 Jul; 32(32):4014. PubMed ID: 24837778
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
    J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.